NADAC acquisition cost data for AZSTARYS 26.1 MG-5.2 MG CAP. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 65038028699 | $12.32 | 2022-11-23 | Rx |
| 65038028699 | $12.32 | 2022-11-23 | Rx |
| 65038028699 | $12.32 | 2022-11-23 | Rx |
| 65038028699 | $12.32 | 2022-11-23 | Rx |
| 65038028699 | $12.32 | 2022-11-23 | Rx |
| 65038028699 | $12.32 | 2022-11-23 | Rx |
Generic: Serdexmethylphen/Dexmethylphen | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A |
| 2021 | $4.2K | 12 | N/A | $13.53 |
| 2022 | $159.7K | 402 | 176 | $13.62 |
| 2023 | $1.4M | 3,223 | 958 | $14.02 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New York | $97.8K | 229 | 69 |
| Florida | $96.8K | 234 | 64 |
| Texas | $93.9K | 215 | 71 |
| Ohio | $81.0K | 195 | 49 |
| Indiana | $77.5K | 175 | 61 |
| Iowa | $69.7K | 166 | 28 |
| Pennsylvania | $64.6K | 161 | 34 |
| Alabama | $64.5K | 151 | 44 |
| Kentucky | $57.6K | 135 | 36 |
| California | $56.1K | 121 | 31 |
| North Carolina | $55.3K | 134 | 42 |
| Michigan | $44.7K | 114 | 33 |
| Connecticut | $41.3K | 103 | 34 |
| Louisiana | $40.9K | 98 | 30 |
| Georgia | $37.9K | 88 | 30 |
| Missouri | $35.3K | 81 | 19 |
| Illinois | $34.7K | 82 | 30 |
| Massachusetts | $32.8K | 80 | 27 |
| Wisconsin | $32.6K | 77 | 26 |
| South Carolina | $23.8K | 56 | 19 |
| Maryland | $19.2K | 43 | 14 |
| West Virginia | $17.7K | 43 | 11 |
| Kansas | $17.6K | 42 | N/A |
| Tennessee | $15.8K | 36 | 15 |
| Maine | $14.5K | 32 | N/A |
| Colorado | $13.4K | 34 | 12 |
| Virginia | $13.3K | 33 | N/A |
| New Jersey | $13.1K | 32 | 14 |
| Idaho | $12.7K | 33 | 14 |
| Arizona | $10.5K | 24 | 11 |
| Oklahoma | $10.1K | 24 | N/A |
| Delaware | $9.8K | 23 | 12 |
| Washington | $9.8K | 15 | N/A |
| Rhode Island | $9.2K | 24 | N/A |
| Arkansas | $8.6K | 21 | N/A |
| Minnesota | $7.7K | 20 | N/A |
| Nevada | $6.0K | 15 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.